Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | RRM1 | P23921 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16163299 | 1.00 | DNM1 (0.44) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL16163198 | 1.00 | DNM1 (0.44) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL16163286 | 1.00 | DNM1 (0.44) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL16163245 | 1.00 | DNM1 (0.44) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL16163293 | 0.98 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL16163136 | 0.98 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL16163418 | 0.98 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL16163250 | 0.98 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL16163355 | 0.98 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL4851820 | 0.98 | OPRM1 (0.41) | DNM1MEN1KMT2AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119869770-A | Combined collector applied to spodumene flotation in low-alkali environment and application thereof | 中南大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119869770-A | Combined collector applied to spodumene flotation in low-alkali environment and application thereof | 中南大学 | 2025-04-25 | — | — | CN | disclosed |
| US-10081655-B2 | Cationic antibacterial composition | JAWAHARLAL NEHRU CENTRE FOR ADVANCED (IN) | 2018-09-25 | — | — | US | disclosed |
| EP-2780359-B1 | CATIONIC ANTIBACTERIAL COMPOSITION | JNCASR BANGALORE (IN) | 2016-02-03 | — | — | EP | disclosed |
| US-20140308347-A1 | CATIONIC ANTIBACTERIAL COMPOSITION | JAWAHARLAL NEHRU CENTRE FOR ADVANCED (IN) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10081655-B2 | Cationic antibacterial composition | SLC11A2, VIP, FPR3 | DNM1 376/4885MEN1 2773/4885KMT2A 4264/4885 |
| US-20140308347-A1 | CATIONIC ANTIBACTERIAL COMPOSITION | VIP, SLC11A2, C9 | DNM1 488/4885MEN1 2693/4885KMT2A 4169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.